Cargando…
Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cells in vitro
BACKGROUND: Antagonists of CXC chemokine receptor 4 (CXCR4), including AMD3100, induce peripheral mobilization of hematopoietic stem cells and have been approved for clinical use. We explored whether the CXCR4 antagonists affected the survival and proliferation of myeloid leukemia cells in vitro. ME...
Autores principales: | Kim, Ha-Yon, Hwang, Ji-Young, Oh, Yoon-Suk, Kim, Seong-Woo, Lee, Hyo-Jin, Yun, Hwan-Jung, Kim, Samyong, Yang, Young-Jun, Jo, Deog-Yeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259516/ https://www.ncbi.nlm.nih.gov/pubmed/22259630 http://dx.doi.org/10.5045/kjh.2011.46.4.244 |
Ejemplares similares
-
The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
por: Kim, Ha-Yon, et al.
Publicado: (2010) -
Expression and functional roles of the chemokine receptor CXCR7 in acute myeloid leukemia cells
por: Kim, Ha-Yon, et al.
Publicado: (2015) -
Bortezomib inhibits the survival and proliferation of bone marrow stromal cells
por: Kim, Ha-Yon, et al.
Publicado: (2015) -
CXCR4 antagonists in hematologic malignancies: more than just mobilizers?
por: Jo, Deog-Yeon
Publicado: (2011) -
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)